- Report
- August 2025
- 178 Pages
Global
From €3210EUR$3,599USD£2,776GBP
- Clinical Trials
- February 2026
- 1549 Pages
Global
From €3077EUR$3,450USD£2,661GBP
- Clinical Trials
- February 2026
- 1320 Pages
Global
From €3077EUR$3,450USD£2,661GBP
- Clinical Trials
- February 2026
- 127 Pages
Global
From €3077EUR$3,450USD£2,661GBP
- Report
- December 2025
Global
From €6689EUR$7,500USD£5,784GBP
- Report
- October 2025
- 17 Pages
Global
From €3344EUR$3,750USD£2,892GBP
- Clinical Trials
- October 2025
- 1457 Pages
Global
From €3077EUR$3,450USD£2,661GBP
- Report
- October 2025
- 15 Pages
Global
From €1338EUR$1,500USD£1,157GBP
- Clinical Trials
- August 2025
- 139 Pages
Global
From €3077EUR$3,450USD£2,661GBP
- Report
- August 2025
- 20 Pages
Global
From €16048EUR$17,995USD£13,878GBP
- Clinical Trials
- July 2025
- 1765 Pages
Global
From €3077EUR$3,450USD£2,661GBP
- Clinical Trials
- July 2025
- 543 Pages
Global
From €3077EUR$3,450USD£2,661GBP
- Clinical Trials
- July 2025
- 989 Pages
Global
From €3077EUR$3,450USD£2,661GBP
- Clinical Trials
- June 2025
Global
From €3077EUR$3,450USD£2,661GBP
- Clinical Trials
- June 2025
Global
From €3077EUR$3,450USD£2,661GBP
- Report
- April 2026
- 180 Pages
Global
From €4455EUR$4,995USD£3,852GBP
- Report
- April 2026
- 192 Pages
Global
From €4455EUR$4,995USD£3,852GBP
- Report
- April 2026
- 188 Pages
Global
From €4455EUR$4,995USD£3,852GBP
- Report
- April 2026
- 192 Pages
Global
From €4455EUR$4,995USD£3,852GBP
- Report
- April 2026
- 192 Pages
Global
From €4455EUR$4,995USD£3,852GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more